Log in

View Full Version : Clinical Trials

Pages : [1] 2 3
  1. Podcast re Vaccine Clinical Trials (0 replies)
  2. Breast cancer vaccine at UW (0 replies)
  3. Breast cancer vaccine safely generates anti-tumor immunity (0 replies)
  4. www.breastcancertrials.org (0 replies)
  5. GP2 immuno therapy (3 replies)
  6. New Vaccine trial for stage 4 patients (3 replies)
  7. MYTESI new drug for diarrhea (2 replies)
  8. Any current vaccine trials (1 replies)
  9. Has anyone been on Neratinib? (6 replies)
  10. BC survivor looking for participants for BC research study (0 replies)
  11. Update to Tucatinib/ONT380 phase 2 trial (5 replies)
  12. Triple Positive research. (6 replies)
  13. Stress Reduction for Young Breast Cancer Survivors (Clinical Trial) (0 replies)
  14. Brain mets (8 replies)
  15. Is anyone on the Keytruda and Kadcyla trial? (0 replies)
  16. Anyone else on the trial S-222611? (4 replies)
  17. Is cancer gene testing and cancer gene sequencing one thing？ (0 replies)
  18. How to find additional funding for a trial (0 replies)
  19. Clinical Trial results (1 replies)
  20. Phase I/II Trial of Ruxolitinib with Trastuzumab in Metastatic HER2+ Breast Cancer (0 replies)
  21. CLEOPATRA for HER2 (2 replies)
  22. Role of microRNA Binding Site Mutations in Cancer (0 replies)
  23. No Travel Required - KRAS-Variant Mutation and Breast Cancer (20 replies)
  24. Effect of Aspirin and Omega-3 Fatty Acids on COX-2 Protein Levels (0 replies)
  25. 5 years of GP2 trial completed! (7 replies)
  26. Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk (8 replies)
  27. While we wait on information for the Neuvax Her2 3+ trial . . . (1 replies)
  28. Ganetespib, Paclitaxel and Trastuzumab for MBC Her2+ (0 replies)
  29. YES!!! It is here. Phase II vaccine trial for Her2 3+ (24 replies)
  30. LIVESTRONG Exercise Program For Cancer Survivors (2 replies)
  31. BrocadeStudy for BRCA1 BRCA2 patients (0 replies)
  32. Perjeta reaction (7 replies)
  33. Dr Pegram talking about a new Her2 phase 2 trial MGHA22 (0 replies)
  34. Understanding the language of clinical trials (1 replies)
  35. Intrathecal Trastuzumab for Leptomeningeal Metastases in HER2+ Breast Cancer (0 replies)
  36. Herceptin Only (2 replies)
  37. Tivatinib (ARQ-197) (9 replies)
  38. Beauty....Breast Cancer Genome Guided Therapy Study (2 replies)
  39. Lapatinib in Treating DCIS (0 replies)
  40. DCIS & Herceptin /Radiation study (0 replies)
  41. Australia study: Denosumab in Young Patients With Primary Breast Cancer (1 replies)
  42. Targeted Chemotherapy for Brain Metastases (0 replies)
  43. Everolimus, Herceptin & Vinorelbine for HER2+ Brain Metastases (1 replies)
  44. Pazopanib, Pemetrexed and Crizotinib for Advanced Disease (3 replies)
  45. MM-302 with Advanced Breast Cancer (5 replies)
  46. Repost for TDM1 trial - thanks Schoonder (0 replies)
  47. Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Canc (0 replies)
  48. Cabergoline in Metastatic Breast Cancer (0 replies)
  49. Fish Oil vs Cox-2 inhibitor in Pregnancy Associated Breast Cancer (0 replies)
  50. PD0332991(Palbociclib)/Paclitaxel in Advanced Breast Cancer (0 replies)
  51. A Study of PI3-Kinase Inhibitor GDC-0941 (6 replies)
  52. Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Ne (0 replies)
  53. A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adju (2 replies)
  54. D081AC00001 Food Interaction With Olaparib Capsule in Patients With Solid Tumours (0 replies)
  55. Phase II Boston area MBC Herceptin, Perjeta & Havalen (0 replies)
  56. Ganetespib For Metastatic HER2+ or Triple Negative Disease (0 replies)
  57. Another way of looking for a clinical trial (0 replies)
  58. Women with early-stage breast cancer on hormonal therapy and experiencing joint pain (0 replies)
  59. A Study of Pertuzumab in Combination With Herceptin (Trastuzumab) And Vinorelbine in (0 replies)
  60. Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive (0 replies)
  61. Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation i (0 replies)
  62. Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Br (0 replies)
  63. First line Treatment - Perjeta for MBC (0 replies)
  64. Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relaps (0 replies)
  65. Phase I Dose-escalation Trial of ARRY-380 in Combination With Trastuzumab in Particip (2 replies)
  66. HKI-272 for HER2-Positive Breast Cancer and Brain Metastases (10 replies)
  67. Spit4science.com (0 replies)
  68. Clinical trials for Neratinib: (0 replies)
  69. TDM1 trial (KATHERINE) Phase III (3 replies)
  70. Vaccines show a 43% reduction in recurrence (1 replies)
  71. Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer (0 replies)
  72. Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing (0 replies)
  73. Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Patients With (0 replies)
  74. Her2 and TGFBeta CTLs in Treatment of Her2 Positive Malignancy (HERCREEM) (0 replies)
  75. ASCO 2013 - Elizabeth A. Mittendorf, M.D., Ph.D., HER2 Peptide (0 replies)
  76. Dr. Mittendorf on Peptide Vaccines for the Treatment of Breast Cancer (0 replies)
  77. 'Do Clinical Trials Work?' -- NY Times Op-ed Misses An Opportunity To Teach And Inste (0 replies)
  78. Do Clinical Trials Work? (0 replies)
  79. Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relaps (0 replies)
  80. Preoperative TDM1 in Germany (0 replies)
  81. TDM1 trial (KATHERINE) Phase III (0 replies)
  82. Imaging With 111 Indium (111In)-Pertuzumab (PmAb) to Predict Response to Trastuzumab (0 replies)
  83. Trastuzumab & Pertuzumab Followed by T-DM1 in MBC (0 replies)
  84. I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Can (0 replies)
  85. HER2 trial (1 replies)
  86. NeuVax reduces recurrence by 78.4% over 5 years (12 replies)
  87. Cancer Vaccines self-sabotage (1 replies)
  88. Canadian study on OncotypeDX. Eh? (0 replies)
  89. Calgb 9840 (0 replies)
  90. Having Radiation Therapy? Try Tumeric (6 replies)
  91. Nail issues while on Metformin (0 replies)
  92. Postmeno trial for bc patients for diet and exercise (0 replies)
  93. Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatme (0 replies)
  94. Excited but anxious going to Mayo for Trial (1 replies)
  95. Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma (0 replies)
  96. TDM1 trial for locally advanced and MBC (0 replies)
  97. DTC Study Recruiting (0 replies)
  98. Vaccine (12 replies)
  99. starting T-DM1 - what to expect? (3 replies)
  100. What we don't know can, in fact, hurt us! (1 replies)
  101. Friend taking PARP Inhibitors (0 replies)
  102. Filtering through personalized information not frustrating anymore (0 replies)
  103. Aphinity study (0 replies)
  104. Need help-hemo dropped and trial postponed (7 replies)
  105. Beginning a clinical trial at MDAnderson (3 replies)
  106. Started TDM1 clinical trial in Nashville (1 replies)
  107. How do the vaccines differ? (1 replies)
  108. waiting for oncologist now in the office (2 replies)
  109. Bolero-2 (1 replies)
  110. Call Karen if you are interested in the AE37/GP2 clinical trial! (0 replies)
  111. Latest T-DM1 site openings - updated as we get them (22 replies)
  112. Check the announcement above from genentech on t-dm1 (2 replies)
  113. Which vaccine trial seems the most promising? (3 replies)
  114. Insurance coverage (1 replies)
  115. Going to Nashville for TDM1 trial. Have questions! (1 replies)
  116. IPT therapy (6 replies)
  117. On the way home from my last visit (6 replies)
  118. VIDEO: Dr. Dennis Slamon Discusses the Importance of Participating in Clinical Trials (3 replies)
  119. Genentech’s TH3RESA trial has many locations (0 replies)
  120. eniluracil/5-FU/leucovorin (0 replies)
  121. Allostim (2 replies)
  122. Herceptin - 3 more treatments to go! (4 replies)
  123. Numerous Vaccine Trials (5 replies)
  124. Vaccine trial (2 replies)
  125. T-DM1 new sites (7 replies)
  126. Anyone on TDM1??? (16 replies)
  127. Next week is my booster visit (7 replies)
  128. Mammaglobin-A DNA vaccine (2 replies)
  129. Breast Cancer Study in Philadelphia (1 replies)
  130. Reconstruction with Neratinib? (0 replies)
  131. Immune Therapy Trial for Stage IV BC (1 replies)
  132. Phase II vaccine trial...looking for info (10 replies)
  133. Important re Trial for Tykerb alone in Adjuvant setting (0 replies)
  134. Clinical Trial LCC0418 Phase II (1 replies)
  135. Genentech PI3K inhibitor Phase I result (0 replies)
  136. Herceptin trial for patients with DCIS (1 replies)
  137. Imetelstat With Paclitaxel (W/,Without Avast) for recurrent and mets bc (0 replies)
  138. TDM1 EAP -Good news for those in TDM1 EAP who need to travel (7 replies)
  139. Phase III Randomized Study of Neoadjuvant Paclitaxel in Combination With Trastuzumab (2 replies)
  140. BCT adds Halaven to its list (0 replies)
  141. Vaccine "cures" Her2 in mice (11 replies)
  142. In vitro/vivo trial Curcumin and/or Herceptin (19 replies)
  143. Emila (T DM1) Clinical Trial (3 replies)
  144. Videos from BCT (0 replies)
  145. Another trial for triple positive stage three breast cancer? (0 replies)
  146. Johns Hopkins Her2 Vaccine Trial (22 replies)
  147. Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progressi (2 replies)
  148. New HER2 vaccine trial to watch for (9 replies)
  149. Access to T DM-1 (60 replies)
  150. Nervous about ALLTO (1 replies)
  151. Clinical Trial for Breast Cancer Skin Mets (2 replies)
  152. Good Resource for Clinical Trial Information (2 replies)
  153. Inflammatory Breast Cancer Clinical Trial for Her2 positive patients (0 replies)
  154. Breast Cancer Clinical Trials website (1 replies)
  155. Medscape: Absolute Benefits of Medical Therapies in Phase III Clinical Trials (1 replies)
  156. I-SPY phase 2 (5 replies)
  157. Clinical Trials without Chemo. (0 replies)
  158. Johns Hopkins is viewing cell behavior in three dimensions (3D) (6 replies)
  159. Itching!!! (5 replies)
  160. Help with Neratinib (3 replies)
  161. Tdmi trial (2 replies)
  162. I-SPY2 trial enrollment (0 replies)
  163. Arizona: CPI-613 trial (alpha lipoic analog) (2 replies)
  164. Thermochemotherapy in Houston (0 replies)
  165. GP2 peptide vaccine Phase II (0 replies)
  166. Everolimus Helps Overcome Herceptin Resistance (4 replies)
  167. Mayo Clinic vaccine trial (0 replies)
  168. I am on the Vaccine in Washington would like to chat with anyone on same vaccine (30 replies)
  169. Purged Circulating Tumor Cells (CTCs) From Met Breast Cancer (Phase II, <60 yrs) (0 replies)
  170. Metformin and Temsirolimus: Metastatic or Unresectable Solid Tumor (Ontario CA) (0 replies)
  171. Zangmeister Center (3 replies)
  172. MediGene completes patient recruitment into EndoTAGTM-1 phase II breast cancer trial (0 replies)
  173. LIFT (leukocyte infusion therapy) (7 replies)
  174. New Clinical Trial Matching Program (0 replies)
  175. Sornefib (Nexavar) trial (0 replies)
  176. som etargeted early phase trials for advanced solid tumors (0 replies)
  177. Mayo Clinic Vaccine Trial MUC1/Neuvax (17 replies)
  178. Herceptin not Primary treatment? (0 replies)
  179. AT-406 trials beginning (0 replies)
  180. Neratinib Clinical Trial (104 replies)
  181. Phase I/II dendritic cell therapy using the oncofetal antigen OFA (0 replies)
  182. Exciting - Scientists kill cancer cells with "trojan horse" (0 replies)
  183. Revamping the Grant Process (1 replies)
  184. DIGNITY Study (2 replies)
  185. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer (0 replies)
  186. Cancer stem cell related trials (1 replies)
  187. Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer (0 replies)
  188. Drug made from virus extends patients' lives (0 replies)
  189. Ariad Begins Clinical Trial of oral deforolimus, mTOR inhibitor (0 replies)
  190. Genentech Clinical Trials T-DM1 and Omnitarg (1 replies)
  191. Phase III T-DM1 (8 replies)
  192. ImmunoGen Q39 Financial Results (aka TDM1 update) (0 replies)
  193. Fat droplet nanoparticle delivers tumor suppressor gene to tumor and metastatic cells (1 replies)
  194. Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Ca (2 replies)
  195. Phase 2 Trial of IPI-504 in Combination With Herceptin (1 replies)
  196. Early Detection of Brain Metastases from Advanced Breast Cancer Through Education and (4 replies)
  197. Vaccine trial in Melbourne (0 replies)
  198. anyone on this ?-New Peptide-Based Vaccine Trial opened with the Tumor Vaccine Group (36 replies)
  199. Cx-4945 (0 replies)
  200. Genetech's upcoming plans with T-DM1 (4 replies)
  201. Triple VEGF Receptor Inhibitor AV-951 (0 replies)
  202. T-DMI = Who is on this? How is it doing? (2 replies)
  203. Bavituximab meet trial goal (0 replies)
  204. 'Targeted Chemo' Safely Shrinks Liver Tumors (15 replies)
  205. CT Scan results (6 replies)
  206. Breast Cancer Vaccine at UAMC (0 replies)
  207. Pertuzumab May Re-sensitize Cells to Herceptin (1 replies)
  208. UAMS to begin testing bc vaccine=carbo antigen based (0 replies)
  209. Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast (0 replies)
  210. Lapatinib trials for 4 yrs out? (3 replies)
  211. Phase I VTX-2337 (TLR8 Agonist ) trial at Mayo in Arizona (2 replies)
  212. Phase II Trial Trying to Arrest Drug Resistance (0 replies)
  213. Phase 2 Study of IMC-A12 (1 replies)
  214. '2-headed' antibody (0 replies)
  215. new neoadjuvant non-anthracycline containing trial (0 replies)
  216. BZL101 trial (oral botanical drug) (1 replies)
  217. positive data from a Phase I clinical trial of carfilzomib (1 replies)
  218. SuperGen's MP-470 (0 replies)
  219. TH-302 for Solid Tumors (0 replies)
  220. GRN163L Sensitizes Resistant Breast Cancer Cells to Trastuzumab (0 replies)
  221. news on trastuzumab-dm1/ itsa GO (16 replies)
  222. Myocet - An encapsulated form of Adriamycin (1 replies)
  223. asco phase 2 results for trastuzumab dm1 (4 replies)
  224. Stage 1 means what, exactly? (1 replies)
  225. new trastuzumab-dm1 trial beginning (5 replies)
  226. If there's phase 3, were there p1 and p2? (0 replies)
  227. Zometa trail? (1 replies)
  228. Phase 3 Study Of IMC-1121B (0 replies)
  229. Individualized Online Clinical Trial Protocol Version 1.0 (9 replies)
  230. trial of resveratrol closer (5 replies)
  231. Adjuvant trial, trastuzumab and paclitaxel for node-negatives (0 replies)
  232. Searching for Clinical Trials (0 replies)
  233. new t-mcc-dm1 trial - anyone know more? (7 replies)
  234. Phase 2 Clinical Trial of Oral Deforolimus (0 replies)
  235. Inducing Increased ER expression in ER negative/low HER2 pos (3 replies)
  236. 72% efficacy with 58 patients over 2 1/2 years with Salicinium. (3 replies)
  237. Trial, vaginal testosterone vs Estring (1 replies)
  238. Phase II Trial Of CR011-vcMMAE (0 replies)
  239. BC Vaccine trial at Wake Forrest (0 replies)
  240. Accidental fungus leads to promising cancer drug (1 replies)
  241. “Cure” in Mice to be Tested in Humans (21 replies)
  242. Vaccine Successfully Enters Phase-II Trial (20 replies)
  243. Eric I think this is a good news ....check out ... (0 replies)
  244. never sure where to post this stuff (1 replies)
  245. ALTTO Trial - Herceptin / Tykerb (17 replies)
  246. Phase I/II Clinical Trial of AXl1717 (3 replies)
  247. T-DM1 - 2nd tumor markers very good (10 replies)
  248. Pg-11047 (0 replies)
  249. Eribulin Mesylate (0 replies)
  250. herceptin & mcc-dm1 criteria question (3 replies)